<DOC>
	<DOCNO>NCT00503360</DOCNO>
	<brief_summary>This study evaluate tolerability safety SAD448 explore compound 's effect intraocular pressure subject ocular hypertension .</brief_summary>
	<brief_title>Tolerability , Safety Efficacy SAD448 Subjects With Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<criteria>Key inclusion criterion : Males female , 18 65 year age , ocular hypertension Females must postmenopausal surgically sterile Key exclusion criterion : Diagnosis glaucoma either eye A history current eye condition medical problem would prohibit use investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Ocular Hypertension</keyword>
	<keyword>SAD448</keyword>
</DOC>